Total: £ 56.28
Published Date: 2026-03-23 | Pages: 111 | Tables: 116 | New Technology
The global Animal Regenerative Medicine and Stem Cell Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
The North American market for Animal Regenerative Medicine and Stem Cell Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Animal Regenerative Medicine and Stem Cell Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Animal Regenerative Medicine and Stem Cell Therapy in Veterinary Hospitals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Animal Regenerative Medicine and Stem Cell Therapy include Ardent Animal Health, VetStem, Medrego, Vetbiologics, Vetherapy, Celavet, Magellan Stem Cells, Animal General, Stem Care Company, Animal Cell Therapies, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report focuses on the global Animal Regenerative Medicine and Stem Cell Therapy status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Animal Regenerative Medicine and Stem Cell Therapy development in different regions.
It segments the global Animal Regenerative Medicine and Stem Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Animal Regenerative Medicine and Stem Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Segment by Application
Veterinary Hospitals
Research Organizations
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Regenerative Medicine and Stem Cell Therapy Market Size Growth Rate by Type (2026-2032)
1.2.2 Dogs Stem Cell Therapy
1.2.3 Horses Stem Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Animal Regenerative Medicine and Stem Cell Therapy Market Share by Application (2026-2032)
1.3.2 Veterinary Hospitals
1.3.3 Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Animal Regenerative Medicine and Stem Cell Therapy Market Size
2.2 Animal Regenerative Medicine and Stem Cell Therapy Market Size by Region
2.2.1 Animal Regenerative Medicine and Stem Cell Therapy Growth Rate by Region (2026-2032)
2.2.2 Animal Regenerative Medicine and Stem Cell Therapy Market Share by Region (2026-2032)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Animal Regenerative Medicine and Stem Cell Therapy Revenue by Players (2026 & 2032)
3.2 Animal Regenerative Medicine and Stem Cell Therapy Key Players Headquarters and Area Served
3.3 Key Players Animal Regenerative Medicine and Stem Cell Therapy Product/Solution/Service
3.4 Date of Enter into Animal Regenerative Medicine and Stem Cell Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and Application
4.1 Global Animal Regenerative Medicine and Stem Cell Therapy Market Size by Type (2026-2032)
4.2 Global Animal Regenerative Medicine and Stem Cell Therapy Market Size by Application (2026-2032)
5 North America
5.1 North America Animal Regenerative Medicine and Stem Cell Therapy Market Forecast (2026-2032)
5.2 Animal Regenerative Medicine and Stem Cell Therapy Key Players in North America
5.3 North America Animal Regenerative Medicine and Stem Cell Therapy Market Size by Type
5.4 North America Animal Regenerative Medicine and Stem Cell Therapy Market Size by Application
6 Europe
6.1 Europe Animal Regenerative Medicine and Stem Cell Therapy Market Forecast (2026-2032)
6.2 Animal Regenerative Medicine and Stem Cell Therapy Key Players in Europe
6.3 Europe Animal Regenerative Medicine and Stem Cell Therapy Market Size by Type
6.4 Europe Animal Regenerative Medicine and Stem Cell Therapy Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Animal Regenerative Medicine and Stem Cell Therapy Market Forecast (2026-2032)
7.2 Animal Regenerative Medicine and Stem Cell Therapy Key Players in Asia-Pacific
7.3 Asia-Pacific Animal Regenerative Medicine and Stem Cell Therapy Market Size by Type
7.4 Asia-Pacific Animal Regenerative Medicine and Stem Cell Therapy Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America Animal Regenerative Medicine and Stem Cell Therapy Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Animal Regenerative Medicine and Stem Cell Therapy Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Players Profiles
9.1 Ardent Animal Health
9.1.1 Ardent Animal Health Company Details
9.1.2 Ardent Animal Health Description and Business Overview
9.1.3 Ardent Animal Health Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.1.4 Ardent Animal Health Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.1.5 Ardent Animal Health Recent Development
9.2 VetStem
9.2.1 VetStem Company Details
9.2.2 VetStem Description and Business Overview
9.2.3 VetStem Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.2.4 VetStem Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.2.5 VetStem Recent Development
9.3 Medrego
9.3.1 Medrego Company Details
9.3.2 Medrego Description and Business Overview
9.3.3 Medrego Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.3.4 Medrego Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.3.5 Medrego Recent Development
9.4 Vetbiologics
9.4.1 Vetbiologics Company Details
9.4.2 Vetbiologics Description and Business Overview
9.4.3 Vetbiologics Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.4.4 Vetbiologics Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.4.5 Vetbiologics Recent Development
9.5 Vetherapy
9.5.1 Vetherapy Company Details
9.5.2 Vetherapy Description and Business Overview
9.5.3 Vetherapy Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.5.4 Vetherapy Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.5.5 Vetherapy Recent Development
9.6 Celavet
9.6.1 Celavet Company Details
9.6.2 Celavet Description and Business Overview
9.6.3 Celavet Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.6.4 Celavet Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.6.5 Celavet Recent Development
9.7 Magellan Stem Cells
9.7.1 Magellan Stem Cells Company Details
9.7.2 Magellan Stem Cells Description and Business Overview
9.7.3 Magellan Stem Cells Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.7.4 Magellan Stem Cells Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.7.5 Magellan Stem Cells Recent Development
9.8 Animal General
9.8.1 Animal General Company Details
9.8.2 Animal General Description and Business Overview
9.8.3 Animal General Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.8.4 Animal General Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.8.5 Animal General Recent Development
9.9 Stem Care Company
9.9.1 Stem Care Company Company Details
9.9.2 Stem Care Company Description and Business Overview
9.9.3 Stem Care Company Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.9.4 Stem Care Company Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.9.5 Stem Care Company Recent Development
9.10 Animal Cell Therapies
9.10.1 Animal Cell Therapies Company Details
9.10.2 Animal Cell Therapies Description and Business Overview
9.10.3 Animal Cell Therapies Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.10.4 Animal Cell Therapies Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.10.5 Animal Cell Therapies Recent Development
9.11 Cell Therapy Sciences
9.11.1 Cell Therapy Sciences Company Details
9.11.2 Cell Therapy Sciences Description and Business Overview
9.11.3 Cell Therapy Sciences Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.11.4 Cell Therapy Sciences Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.11.5 Cell Therapy Sciences Recent Development
9.12 Animacel
9.12.1 Animacel Company Details
9.12.2 Animacel Description and Business Overview
9.12.3 Animacel Animal Regenerative Medicine and Stem Cell Therapy Introduction
9.12.4 Animacel Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business (2026 & 2032)
9.12.5 Animacel Recent Development
10 Animal Regenerative Medicine and Stem Cell Therapy Market Dynamics
10.1 Animal Regenerative Medicine and Stem Cell Therapy Industry Trends
10.2 Animal Regenerative Medicine and Stem Cell Therapy Market Drivers
10.3 Animal Regenerative Medicine and Stem Cell Therapy Market Challenges
10.4 Animal Regenerative Medicine and Stem Cell Therapy Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details
List of Tables
Table 1. Global Animal Regenerative Medicine and Stem Cell Therapy Market Size Growth Rate by Type (2026-2032) & (US$ Million)
Table 2. Key Players of Dogs Stem Cell Therapy
Table 3. Key Players of Horses Stem Cell Therapy
Table 4. Key Players of Others
Table 5. Global Animal Regenerative Medicine and Stem Cell Therapy Market Size Growth by Application (2026-2032) & (US$ Million)
Table 6. Global Animal Regenerative Medicine and Stem Cell Therapy Market Size by Region (2026-2032) & (US$ Million)
Table 7. Global Animal Regenerative Medicine and Stem Cell Therapy Market Size by Region (2026-2032) & (US$ Million)
Table 8. Global Animal Regenerative Medicine and Stem Cell Therapy Market Share by Region (2026-2032)
Table 9. Market Top Trends
Table 10. Market Use Cases
Table 11. Global Animal Regenerative Medicine and Stem Cell Therapy Revenue by Players (2026 & 2032) & (US$ Million)
Table 12. Global Animal Regenerative Medicine and Stem Cell Therapy Market Share by Players (2026 & 2032)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Animal Regenerative Medicine and Stem Cell Therapy Product/Solution/Service
Table 15. Date of Enter into Animal Regenerative Medicine and Stem Cell Therapy Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Animal Regenerative Medicine and Stem Cell Therapy Market Size by Type (2026-2032) & (US$ Million)
Table 18. Global Animal Regenerative Medicine and Stem Cell Therapy Market Size Share by Type (2026-2032)
Table 19. Global Animal Regenerative Medicine and Stem Cell Therapy Market Size by Application (2026-2032) & (US$ Million)
Table 20. Global Animal Regenerative Medicine and Stem Cell Therapy Market Size Share by Application (2026-2032)
Table 21. North America Key Players Animal Regenerative Medicine and Stem Cell Therapy Revenue (2026 & 2032) & (US$ Million)
Table 22. North America Key Players Animal Regenerative Medicine and Stem Cell Therapy Market Share (2026 & 2032)
Table 23. North America Animal Regenerative Medicine and Stem Cell Therapy Market Size by Type (2026-2032) & (US$ Million)
Table 24. North America Animal Regenerative Medicine and Stem Cell Therapy Market Share by Type (2026-2032)
Table 25. North America Animal Regenerative Medicine and Stem Cell Therapy Market Size by Application (2026-2032) & (US$ Million)
Table 26. North America Animal Regenerative Medicine and Stem Cell Therapy Market Share by Application (2026-2032)
Table 27. Europe Key Players Animal Regenerative Medicine and Stem Cell Therapy Revenue (2026 & 2032) & (US$ Million)
Table 28. Europe Key Players Animal Regenerative Medicine and Stem Cell Therapy Market Share (2026 & 2032)
Table 29. Europe Animal Regenerative Medicine and Stem Cell Therapy Market Size by Type (2026-2032) & (US$ Million)
Table 30. Europe Animal Regenerative Medicine and Stem Cell Therapy Market Share by Type (2026-2032)
Table 31. Europe Animal Regenerative Medicine and Stem Cell Therapy Market Size by Application (2026-2032) & (US$ Million)
Table 32. Europe Animal Regenerative Medicine and Stem Cell Therapy Market Share by Application (2026-2032)
Table 33. Asia-Pacific Key Players Animal Regenerative Medicine and Stem Cell Therapy Revenue (2026 & 2032) & (US$ Million)
Table 34. Asia-Pacific Key Players Animal Regenerative Medicine and Stem Cell Therapy Market Share (2026 & 2032)
Table 35. Asia-Pacific Animal Regenerative Medicine and Stem Cell Therapy Market Size by Type (2026-2032) & (US$ Million)
Table 36. Asia-Pacific Animal Regenerative Medicine and Stem Cell Therapy Market Share by Type (2026-2032)
Table 37. Asia-Pacific Animal Regenerative Medicine and Stem Cell Therapy Market Size by Application (2026-2032) & (US$ Million)
Table 38. Asia-Pacific Animal Regenerative Medicine and Stem Cell Therapy Market Share by Application (2026-2032)
Table 39. Key Players in Latin America
Table 40. Key Players in Middle East & Africa
Table 41. Ardent Animal Health Company Details
Table 42. Ardent Animal Health Description and Business Overview
Table 43. Ardent Animal Health Animal Regenerative Medicine and Stem Cell Therapy Product
Table 44. Ardent Animal Health Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 45. Ardent Animal Health Recent Development
Table 46. VetStem Company Details
Table 47. VetStem Description and Business Overview
Table 48. VetStem Animal Regenerative Medicine and Stem Cell Therapy Product
Table 49. VetStem Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 50. VetStem Recent Development
Table 51. Medrego Company Details
Table 52. Medrego Description and Business Overview
Table 53. Medrego Animal Regenerative Medicine and Stem Cell Therapy Product
Table 54. Medrego Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 55. Medrego Recent Development
Table 56. Vetbiologics Company Details
Table 57. Vetbiologics Description and Business Overview
Table 58. Vetbiologics Animal Regenerative Medicine and Stem Cell Therapy Product
Table 59. Vetbiologics Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 60. Vetbiologics Recent Development
Table 61. Vetherapy Company Details
Table 62. Vetherapy Description and Business Overview
Table 63. Vetherapy Animal Regenerative Medicine and Stem Cell Therapy Product
Table 64. Vetherapy Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 65. Vetherapy Recent Development
Table 66. Celavet Company Details
Table 67. Celavet Description and Business Overview
Table 68. Celavet Animal Regenerative Medicine and Stem Cell Therapy Product
Table 69. Celavet Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 70. Celavet Recent Development
Table 71. Magellan Stem Cells Company Details
Table 72. Magellan Stem Cells Description and Business Overview
Table 73. Magellan Stem Cells Animal Regenerative Medicine and Stem Cell Therapy Product
Table 74. Magellan Stem Cells Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 75. Magellan Stem Cells Recent Development
Table 76. Animal General Company Details
Table 77. Animal General Description and Business Overview
Table 78. Animal General Animal Regenerative Medicine and Stem Cell Therapy Product
Table 79. Animal General Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 80. Animal General Recent Development
Table 81. Stem Care Company Company Details
Table 82. Stem Care Company Description and Business Overview
Table 83. Stem Care Company Animal Regenerative Medicine and Stem Cell Therapy Product
Table 84. Stem Care Company Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 85. Stem Care Company Recent Development
Table 86. Animal Cell Therapies Company Details
Table 87. Animal Cell Therapies Description and Business Overview
Table 88. Animal Cell Therapies Animal Regenerative Medicine and Stem Cell Therapy Product
Table 89. Animal Cell Therapies Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 90. Animal Cell Therapies Recent Development
Table 91. Cell Therapy Sciences Company Details
Table 92. Cell Therapy Sciences Description and Business Overview
Table 93. Cell Therapy Sciences Animal Regenerative Medicine and Stem Cell Therapy Product
Table 94. Cell Therapy Sciences Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 95. Cell Therapy Sciences Recent Development
Table 96. Animacel Company Details
Table 97. Animacel Description and Business Overview
Table 98. Animacel Animal Regenerative Medicine and Stem Cell Therapy Product
Table 99. Animacel Revenue in Animal Regenerative Medicine and Stem Cell Therapy Business: 2026 & 2032
Table 100. Animacel Recent Development
Table 101. Animal Regenerative Medicine and Stem Cell Therapy Market Trends
Table 102. Animal Regenerative Medicine and Stem Cell Therapy Market Drivers
Table 103. Animal Regenerative Medicine and Stem Cell Therapy Market Challenges
Table 104. Animal Regenerative Medicine and Stem Cell Therapy Market Restraints
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Animal Regenerative Medicine and Stem Cell Therapy Market Share by Type in 2026 & 2032
Figure 2. Dogs Stem Cell Therapy Features
Figure 3. Horses Stem Cell Therapy Features
Figure 4. Others Features
Figure 5. Global Animal Regenerative Medicine and Stem Cell Therapy Market Share by Application in 2026 & 2032
Figure 6. Veterinary Hospitals Case Studies
Figure 7. Research Organizations Case Studies
Figure 8. Animal Regenerative Medicine and Stem Cell Therapy Report Years Considered
Figure 9. Global Animal Regenerative Medicine and Stem Cell Therapy Market Size and Growth Rate 2026-2032 (US$ Million)
Figure 10. Global Animal Regenerative Medicine and Stem Cell Therapy Market Share by Region (2026-2032)
Figure 11. Global Animal Regenerative Medicine and Stem Cell Therapy Market Size Market Share by Type (2026-2032)
Figure 12. North America Animal Regenerative Medicine and Stem Cell Therapy Market Size 2026-2032 (US$ Million)
Figure 13. Europe Animal Regenerative Medicine and Stem Cell Therapy Market Size 2026-2032 (US$ Million)
Figure 14. Asia-Pacific Animal Regenerative Medicine and Stem Cell Therapy Market Size 2026-2032 (US$ Million)
Figure 15. Animal Regenerative Medicine and Stem Cell Therapy Market Size in Latin America (2026-2032) & (US$ Million)
Figure 16. Animal Regenerative Medicine and Stem Cell Therapy Market Size in Middle East & Africa (2026-2032) & (US$ Million)
Figure 17. Bottom-up and Top-down Approaches for This Report
Figure 18. Data Triangulation
Figure 19. Key Executives Interviewed